Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT01366209 · COMPLETED
Trial details
- NCT number
- NCT01366209
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2014-02-01
- Enrollment
- 555
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.